This year a record of 581 submissions were received from nearly 400 universities across the globe. Submissions consisted of a representative, peer-reviewed published research paper accompanied by a PhD's supervisor recommendation letter and CV. Entries were closely scrutinized by a review board of over 100 international chemists from academia and industry. The reviewers judged the entries for originality, innovation, importance to the field, applicability, rigor of approach and publication quality.
The three winners and 42 remaining finalists have been invited to attend the Reaxys Inspiring Chemistry Conference which will be held in Grindelwald, Switzerland, September 22 - 24, 2013 where they will be given the opportunity to present their research.
For more information about Reaxys go to http://www.elsevier.com/reaxysAbout Reaxys Reaxys® is a workflow solution for research chemists. Offering a wealth of experimentally validated information, Reaxys® combines reaction and substance data in organic, organometallic, inorganic and physical chemistry with synthesis planning. Researchers can get the information they need in a single overview, from source publications carefully selected for their importance and relevance to research chemists. Elsevier continues to engage with the chemistry community to ensure that Reaxys® continues to reflect how chemists think and work. For more information please visit Reaxys. Reaxys® and the Reaxys® trademark are owned and protected by Reed Elsevier Properties SA and used under license. About Reed Elsevier Properties SA Reed Elsevier Properties SA is a centre of excellence within Reed Elsevier for the management, development and protection of intellectual property. Reed Elsevier Properties SA owns the PharmaPendium and Reaxys databases. Trademarks including Reaxys®, PharmaPendium®, Targetinsights™, The Lancet® and World Travel Market® are owned and protected by Reed Elsevier Properties SA and used under licence. About Elsevier
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts